Abbott Labs's most recent trend suggests a bullish bias. One trading opportunity on Abbott Labs is a Bull Put Spread using a strike $127.00 short put and a strike $122.00 long put offers a potential 32.63% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $127.00 by expiration. The full premium credit of $1.23 would be kept by the premium seller. The risk of $3.77 would be incurred if the stock dropped below the $122.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Abbott Labs is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Abbott Labs is bullish.
The RSI indicator is above 80 which suggests that the stock is in overbought territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Abbott Labs
Real Sustainability Is About People
Fri, 29 Oct 2021 12:17:10 +0000
Robert B Ford and Abbott are leading the charge for greater access to affordable healthcare technologies.
4 Medical Products Stocks Poised to Beat This Earnings Season
Thu, 28 Oct 2021 14:29:02 +0000
Amid concerns surrounding growing COVID-19 cases affecting the medical products companies' legacy business, we are optimistic about IDXX, HSIC, CGC and PODD's results this time around.
CONMED's (CNMD) Q3 Earnings Beat Estimates, Revenues Miss
Thu, 28 Oct 2021 13:59:01 +0000
CONMED's (CNMD) third-quarter earnings reflect strong segmental performance.
West Pharmaceutical (WST) Q3 Earnings & Revenues Beat Estimates
Thu, 28 Oct 2021 13:57:01 +0000
West Pharmaceutical's (WST) third-quarter earnings reflect segmental strong performance.
Baxter (BAX) Q3 Earnings and Revenues Surpass Estimates
Thu, 28 Oct 2021 13:47:01 +0000
Baxter's (BAX) third-quarter results reflect robust performance across all its business units.
Related Posts
Also on Market Tamer…
Follow Us on Facebook